Seminars in Oncology
Volume 29, Issue 2 , Pages 107-118 , April 2002

Surgical treatment of liver metastases

References 

  1. Greenlee RT, Hill-Harmon MB, Murray T, et al.  Cancer statistics, 2001. CA Cancer J Clin. 2001;50:7–33
  2. Jessup JM, McGinnis LS, Steele GD, et al.  The National Cancer Data Base. Report on colon cancer. Cancer. 1996;78:918–926
  3. Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg. 1989;124:1021–1022
  4. Weiss L, Grundmann E, Torhorst J, et al.  Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol. 1986;150:195–203
  5. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976;2:285–288
  6. Jaffe BM, Donegan WL, Watson F, et al.  Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968;127:1–11
  7. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969;23:198–202
  8. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg. 1990;77:1241–1246
  9. Adson MA, van Heerden JA, Adson MH, et al.  Resection of hepatic metastases from colorectal cancer. Arch Surg. 1984;119:647–651
  10. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg. 1976;111:330–334
  11. Hughes KS, Simon R, Songhorabodi S, et al.  Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery. 1986;100:278–284
  12. Scheele J, Stang R, Altendorf-Hofmann A, et al.  Resection of colorectal liver metastases. World J Surg. 1995;19:59–71
  13. Nordlinger B, Guiguet M, Vaillant JC, et al.  Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254–1262
  14. Jamison RL, Donohue JH, Nagorney DM, et al.  Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132:505–510
  15. Fong Y, Fortner J, Sun RL, et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318
  16. Hughes KS, Rosenstein RB, Songhorabodi S, et al.  Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rect. 1988;31:1–4
  17. D'Angelica M, Brennan MF, Fortner JG, et al.  Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 1997;185:554–559
  18. Fong Y, Cohen AM, Fortner JG, et al.  Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938–946
  19. Lise M, Bacchetti S, Da Pian P, et al.  Patterns of recurrence after resection of colorectal liver metastases: Prediction by models of outcome analysis. World J Surg. 2001;25:638–644
  20. Iwatsuki S, Dvorchik I, Madariaga JR, et al.  Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291–299
  21. Doci R, Gennari L, Bignami P, et al.  One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 1991;78:797–801
  22. Cady B, Jenkins RL, Steele GD, et al.  Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome. Ann Surg. 1998;227:566–571
  23. Wanebo HJ, Chu QD, Vezeridis MP, et al.  Patient selection for hepatic resection of colorectal metastases. Arch Surg. 1996;131:322–329
  24. Registry of Hepatic Metastases . Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Surgery. 1988;103:278–288
  25. Rashidi B, Gamagami R, Sasson A, et al.  An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. Clin Cancer Res. 2000;6:2556–2561
  26. August DA, Sugarbaker PH, Schneider PD. Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer. 1985;55:1490149
  27. Murata S, Moriya Y, Akasu T, et al.  Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer. 1998;83:1086–1093
  28. Headrick JR, Miller DL, Nagorney DM, et al.  Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg. 2001;71:975–979
  29. Robinson BJ, Rice TW, Strong SA, et al.  Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?. J Thorac Cardiovasc Surg. 1999;117:66–75
  30. Steele G, Bleday R, Mayer RJ, et al.  A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group protocol 6584. J Clin Oncol. 1991;9:1105–1112
  31. Moertel CG, Fleming TR, Macdonald JS, et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352–358
  32. Weber SM, Jarnagin WR, DeMatteo RP, et al.  Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol. 2000;7:643–650
  33. Rosen SA, Buell JF, Yoshida A, et al.  Initial presentation with stage IV colorectal cancer: How aggressive should we be?. Arch Surg. 2000;135:530–534
  34. Povoski SP, Fong Y, Sgouros SC, et al.  Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol. 1998;5:9–15
  35. Fajobi O, Yiu CY, Sen-Gupta SB, et al.  Metachronous colorectal cancers. Br J Surg. 1998;85:897–901
  36. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al.  Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography. Ann Surg Oncol. 1997;4:613–620
  37. Schiepers C, Penninckx F, De Vadder N, et al.  Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol. 1995;21:517–522
  38. Huebner RH, Park KC, Shepherd JE, et al.  A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med. 2000;41:1177–1189
  39. Flamen P, Hoekstra OS, Homans F, et al.  Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET). Eur J Cancer. 2001;37:862–869
  40. Flanagan FL, Dehdashti F, Ogunbiyi OA, et al.  Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg. 1998;227:319–323
  41. Vitola JV, Delbeke D, Sandler MP, et al.  Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg. 1996;171:21–26
  42. Lai DT, Fulham M, Stephen MS, et al.  The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg. 1996;131:703–707
  43. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol. 2000;174:691–698
  44. Kehagias D, Metafa A, Hatziioannou A, et al.  Comparison of CT, MRI and CT during arterial portography in the detection of malignant hepatic lesions. Hepatogastroenterology. 2000;47:1399–1403
  45. Kuszyk BS, Bluemke DA, Urban BA, et al.  Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: Sensitivity based on comparison with intraoperative and pathologic findings. AJR Am J Roentgenol. 1996;166:91–95
  46. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery. 1974;75:589–596
  47. Nelson RC, Chezmar JL, Sugarbaker PH, et al.  Hepatic tumors: Comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology. 1989;172:27–34
  48. Soyer P, Bluemke DA, Hruban RH, et al.  Hepatic metastases from colorectal cancer: Detection and false-positive findings with helical CT during arterial portography. Radiology. 1994;193:71–74
  49. Soyer P, Lacheheb D, Levesque M. False-positive CT portography: Correlation with pathologic findings. AJR Am J Roentgenol. 1993;160:285–289
  50. Seneterre E, Taourel P, Bouvier Y, et al.  Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology. 1996;200:785–792
  51. Couinaud C. Le Foie. Etudes Anatominques et Chirugicales. Paris: France, Masson; 1957;
  52. Strasberg SM. Terminology of liver anatomy and liver resections: Coming to grips with hepatic Babel. J Am Coll Surg. 1997;184:413–434
  53. John TG, Greig JD, Crosbie JL, et al.  Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg. 1994;220:711–719
  54. Rahusen FD, Cuesta MA, Borgstein PJ, et al.  Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg. 1999;230:31–37
  55. Babineau TJ, Lewis WD, Jenkins RL, et al.  Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg. 1994;167:151–154
  56. Jarnagin WR, Bodniewicz J, Dougherty E, et al.  A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg. 2000;4:34–43
  57. Jarnagin WR, Conlon K, Bodniewicz J, et al.  A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer. 2001;91:1121–1128
  58. Staren ED, Gambla M, Deziel DJ, et al.  Intraoperative ultrasound in the management of liver neoplasms. In: Am Surg. 63:1997;p. 591–596
  59. Stadler J, Holscher AH, Adolf J. Intraoperative ultrasonographic detection of occult liver metastases in colorectal cancer. Surg Endosc. 1991;5:36–40
  60. Fortunato L, Clair M, Hoffman J, et al.  Is CT portography (CTAP) really useful in patients with liver tumors who undergo intraoperative ultrasonography (IOUS)?. Am Surg. 1995;61:560–565
  61. Ozsunar Y, Skjoldbye B, Court-Payen M, et al.  Impact of intraoperative ultrasonography on surgical treatment of liver tumours. Acta Radiol. 2000;41:97–101
  62. Foroutani A, Garland AM, Berber E, et al.  Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg. 2000;135:933–938
  63. Barbot DJ, Marks JH, Feld RI, et al.  Improved staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg Oncol. 1997;64:63–67
  64. Kokudo N, Tada K, Seki M, et al.  Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg. 2001;181:153–159
  65. Brown DA, Pommier RF, Woltering EA, et al.  Nonanatomic hepatic resection for secondary hepatic tumors with special reference to hemostatic technique. Arch Surg. 1988;123:1063–1066
  66. Adson MA. Resection of liver metastases—When is it worthwhile?. World J Surg. 1987;11:511–520
  67. Fong Y, Cohen AM, Fortner JG, et al.  Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938–946
  68. Doci R, Gennari L, Bignami P, et al.  Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg. 1995;82:377–381
  69. Que FG, Nagorney DM. Resection of ‘recurrent’ colorectal metastases to the liver. Br J Surg. 1994;81:255–258
  70. Fong Y, Blumgart LH, Cohen A, et al.  Repeat hepatic resections for metastatic colorectal cancer. Ann Surg. 1994;220:657–662
  71. Nordlinger B, Vaillant JC, Guiguet M, et al.  Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol. 1994;12:1149–1491
  72. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery. 1995;117:296–304
  73. Tuttle TM, Curley SA, Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol. 1997;4:125–130
  74. Adam R, Bismuth H, Castaing D, et al.  Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225:51–60
  75. Yamamoto J, Kosuge T, Shimada K, et al.  Repeat liver resection for recurrent colorectal liver metastases. Am J Surg. 1999;178:275–281
  76. Fowler WC, Eisenberg BL, Hoffman JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol. 1992;51:122–125
  77. Elias D, Lasser P, Rougier P, et al.  Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg. 1995;180:213–219
  78. Shankar A, Leonard P, Renaut AJ, et al.  Neo-adjuvant therapy improves resectability rates for colorectal liver metastases. Ann R Coll Surg Engl. 2001;83:85–88
  79. Bismuth H, Adam R, Levi F, et al.  Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509–520
  80. Lorenz M, Muller HH, Staib-Sebler E, et al.  Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma. Langenbecks Arch Surg. 1999;384:328–338
  81. Kokudo N, Seki M, Ohta H, et al.  Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol. 1998;5:706–712
  82. Nitti D, Ciavalleri D, Samori G, et al.  Retrospective study on adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Eur J Surg Oncol. 1994;20:454–460

 Address reprint requests to Elin R. Sigurdson, MD, PhD, Department of Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Ave, Philadelphia, PA 19111.

PII: S0093-7754(02)50131-7

doi: 10.1053/sonc.2002.31676

Seminars in Oncology
Volume 29, Issue 2 , Pages 107-118 , April 2002